Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reissue Patent
2006-06-27
2006-06-27
Pak, John (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S526000, C514S690000, C514S730000, C514S558000, C514S560000, C514S824000, C514S834000, C514S930000, C514S944000, C514S970000, C424S601000, C424S605000, C424S617000, C424S649000, C424S078080, C424S078310, C424S078350, C424S078370, C424S422000, C604S041000, C604S058000
Reissue Patent
active
RE039150
ABSTRACT:
A composition including 2-hexyl cyanoacrylate and goal is useful in treating arteriovenous malformations (AVMs) and other body lumens to be blocked.
REFERENCES:
patent: 4740534 (1988-04-01), Matsuda et al.
patent: 5525334 (1996-06-01), Ito et al.
patent: 5624685 (1997-04-01), Takahashi et al.
patent: 5695480 (1997-12-01), Evans et al.
patent: 5702361 (1997-12-01), Evans et al.
patent: 5759194 (1998-06-01), Hammerslag
patent: 5795331 (1998-08-01), Cragg et al.
patent: 6143352 (2000-11-01), Clark et al.
patent: 6174919 (2001-01-01), Hickey
patent: 6476069 (2002-11-01), Krall et al.
patent: 2002/0018752 (2002-02-01), Krall et al.
patent: 2003/0194389 (2003-10-01), Porter
patent: 99/42535 (1999-08-01), None
Barr, John D., “Temporary and Permanent Occlusion of Cerebral Arteries,”Neuroendovascular Surgery, vol. 11, No. 1, Jan. 2000, pp. 27-38.
Berthelsen, B. et al., “Embolization of Cerebral Arteriovenous Malformations with Bucrylate,”Acta Radiologica, vol. 31, 1990, pp. 13-21.
Freeny, Patrick C. et al., “Transcatheter Therapy of Genitourinary Abnormalities Using Isobutyl 2-Cyanoacrylate (Bucrylate),”AJR, vol. 133, Oct. 1979 pp. 647-656.
Gobin, Dr. Y. Pierre et al., “Treatment of Brain Arteriovenous Malformations by Embolization and Radiosurgery,”J Neurosurg, vol. 85, 1996, pp. 19-28.
Halbach, Dr. Van V. et al., “Preoperative Balloon Occlusion of Arteriovenous Malformations,”Neurosurgery, vol. 22, No. 2, 1988, pp. 301-308.
Kerber, Dr. Charles W. and Wong, Wade, “Liquid Acrylic Adhesive Agents in Interventional Neuroradiology,”Neuroendovascular Surgery, vol. 11, No. 1, Jan. 2000, pp. 85-99.
Lefkowitz, Dr. Michael A. et al., “Balloon-assisted Guglielmi Detachable Coiling of Wide-necked Aneurysms: Part II—Clinical Results,”Neurosurgery, vol. 45, No. 3, Sep. 1999, pp. 531-538.
Levy, Dr. David I., “Embolization of Wide-necked Anterior Communication Artery Aneurysm: Technical Note,”Neurosurgery, vol. 41, No. 4, Oct. 1997, pp. 979-982.
Malek, Dr. Adel M. et al., “Balloon-assist Technique for Endovascular Coil Embolization of Geometrically Difficult Intracranial Aneurysms,”Neurosurgery, vol. 46, No. 6, Jun. 2000, pp. 1397-1407.
Mericle, Robert A., M.D., “Temporary Balloon Protection as an Adjunct to Endosaccular Coiling of Wide-necked Cerebral Aneurysms”,Neurosurgery, vol. 41, No. 4, Oct. 1997, pp. 1992-1998.
Moret, J et al., “The “Remodeling Technique” in the Treatment of Wide Neck Intracranial Aneurysms,”Interventional Neuroradiology, vol. 3, 1997, pp. 21-35.
Pelz, David M. et al., “Preoperative Embolization of Brain AVMs with Isobutyl-2 Cyanoacrylate,”AJNR, vol. 9, Aug. 1988, pp. 757-764.
Rao, V.R.K. et al., “Dissolution of Isobutyl 2-Cyanoacrylate on Long-Term Follow-Up,”AJNR, vol. 10, Jan./Feb. 1989, pp. 135-141.
Spiegel, S. M. et al., “Adjusting the Polymerization Time of Isobutyl-2 Cyanoacrylate,”American Journal of Neuroradiology, vol. 7, Jan./Feb. 1986, pp. 109-112.
Vinuela, F.V. et al., “Dominant-Hemisphere Arteriovenous Malformations: Therapeutic Embolization with Isobutyl-2-Cyanoacrylate,”AJNR, vol. 4, Jul./Aug. 1983, pp. 959-966.
Vinuela, Fernando et al., “Progressive Thrombosis of Brain Arteriovenous Malformations After Embolization with Isobutyl 2-Cyanoacrylate,”AJNR, vol. 4, Nov./Dec. 1983, pp. 1233-1238.
Vinuela, Fernando et al., “Angiographic Follow-Up of Large Cerebral AVMs Incompletely Embolized with Isobutyl-2-Cyanoacrylate,” AJNR, vol. 7, Sep./Oct. 1986, pp. 919-925.
Kerber Charles W.
Knox Kimberly
Krall Robert E.
Gray Cary Ware & Freidenrich LLP
Pak John
Prohold Technologies, Inc.
LandOfFree
Composition for creating vascular occlusions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition for creating vascular occlusions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for creating vascular occlusions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3694430